Atinvicitinib, a novel, second-generation selective JAK1 inhibitor for the treatment of allergic dermatitis and atopic dermatitis in dogs
Timothy Kowalski, Sara Dinverno, Joep Verdellen, Youri Post, Rafael Fernandez, Jason Brubaker, Jonathan Young
Springer Nature ·
2026-11-16
· DOI 10.1186/s12917-026-06047-w
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Timothy Kowalski, Sara Dinverno, Joep Verdellen, Youri Post, Rafael Fernandez, Jason Brubaker et al. Atinvicitinib, a novel, second-generation selective JAK1 inhibitor for the treatment of allergic dermatitis and atopic dermatitis in dogs. // BMC Veterinary Research. – 2026. – DOI: 10.1186/s12917-026-06047-w. – URL: https://doi.org/10.1186/s12917-026-06047-w
Timothy Kowalski, Sara Dinverno, Joep Verdellen, Youri Post, Rafael Fernandez, Jason Brubaker, & Jonathan Young (2026). Atinvicitinib, a novel, second-generation selective JAK1 inhibitor for the treatment of allergic dermatitis and atopic dermatitis in dogs. BMC Veterinary Research. https://doi.org/10.1186/s12917-026-06047-w
Timothy Kowalski, et al. “Atinvicitinib, a novel, second-generation selective JAK1 inhibitor for the treatment of allergic dermatitis and atopic dermatitis in dogs.” BMC Veterinary Research, 2026. doi:10.1186/s12917-026-06047-w.
@article{Kowalski2026,
title = {Atinvicitinib, a novel, second-generation selective JAK1 inhibitor for the treatment of allergic dermatitis and atopic dermatitis in dogs},
author = {Kowalski, Timothy and Dinverno, Sara and Verdellen, Joep and Post, Youri and Fernandez, Rafael and Brubaker, Jason and Young, Jonathan},
journal = {BMC Veterinary Research},
year = {2026},
doi = {10.1186/s12917-026-06047-w},
url = {https://doi.org/10.1186/s12917-026-06047-w}
}